Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

The wigs made from human hair and polypropylene were mostly well-tolerated and durable in rabbits, suggesting they could be a new option for people with extensive hair loss.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The microbiome may be linked to hair loss and could be a target for new treatments.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Wound-induced hair follicle creation is a complex process in adult mammals that involves various cells and immune responses, and understanding it better could help improve skin healing strategies.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Cells in hair follicles help create fat cells in the skin by releasing a protein called Sonic Hedgehog.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Vitamin A affects hair loss and immune response in alopecia areata.